-+ 0.00%
-+ 0.00%
-+ 0.00%

SYNDAX PHARMACEUTICALS - ISSUES $250 MLN OF 2.25% CONVERTIBLE SENIOR NOTES DUE 2031 - SEC FILING

Reuters·06/10/2026 21:05:26

Please log in to view news